Various feature selection algorithms have been proposed to identify cancer prognostic biomarkers. In recent years, however, their reproducibility is criticized. The performance of feature selection algorithms is shown to be affected by the datasets, underlying networks and evaluation metrics. One of the causes is the curse of dimensionality, which makes it hard to select the features that generalize well on independent data. Even the integration of biological networks does not mitigate this issue because the networks are large and many of their components are not relevant for the phenotype of interest. With the availability of multi-omics data, integrative approaches are being developed to build more robust predictive models. In this scenario, the higher data dimensions create greater challenges.
48
adapted Google's PageRank algorithm to rank genes in a network. Genes are assigned 49 initial ranks r [0] ∈ R N . Then the rank of each gene is updated iteratively depending on 50 the ranks of genes that are linked to it. For gene j, its rank from r 
where deg i is the degree of the ith gene and d is a fixed parameter. By iterating until 53 convergence a gene will be highly ranked if it is linked to other highly ranked genes. Table 1 . Frequently used molecular/gene interaction networks in network-based feature selection studies. We listed below the basic information of the networks as well as exemplary studies that employed the networks. With STRING database we only considered the edges with confidence scores ≥ 0.9. When a database has information of many species, only Homo sapiens was considered. In the 4th and 5th columns, Data means that the network size is dependent on the dimensions of data. App means that the network size is dependent on the application. GO means that the network size is dependent on gene ontology terms. Molecular [18] [20] used random walk kernel to smooth gene-wise t-statistics over the network. This is 55 achieved by assigning each node an initial score based on t-test and then multiplying it 56 with the random walk kernel. The p-step random walk kernel is used as a similarity 57 measure to capture the relatedness of two nodes in the network. It is defined as:
where L norm is the normalized graph Laplacian matrix, α is a constant, and p is the 59 number of random walk steps. The network-smoothed t-statistict = t T K is used to 60 measure node importance. Similarly, random walk-based scoring of network components 61 is applied in [21] to prioritize functional networks. algorithms on six breast cancer datasets in prognosis prediction. They showed that the 84 randomization of network structure, which destroyed biological information, did not 85 deteriorate the prediction performance of the selected features. [24] extended the 86 experiments in [23] by comparing more prognosis signatures. In the end, similar results 87 were observed. 88 We suppose that the main reason for these counter-intuitive results is the curse of 89 dimensionality, where selecting molecular signatures is hard given the limited amount of 90 samples. In principle, molecular signatures should give better predictions than random 91 features, because it is shown in biological research that certain genes are supposed to be 92 more important than the others in cancer progression. If we use this information to 93 constrain the feature space and guide feature selection, we could potentially obtain more 94 robust biomarkers. State-of-the-art studies have not utilized this knowledge but 95 considered the whole feature space and the entire biological network. Because both the 96 data and the network are large, the irrelevant information may overwhelm the signals.
97
Furthermore, biological networks were typically integrated with one type of omics data. 98 It would be very interesting to investigate how the prediction performance differs when 99 the networks are integrated with different omics data types, and additionally what are 100 the relationships among the features selected from different omics data.
101
To address this issue, we proposed a phenotype relevant network-based feature 102 selection (PRNFS) framework. It consists of constructing a phenotype relevant gene 103 regulatory network (GRN) and selecting features from this network. We demonstrated 104 the superiority of this framework with the application of lung adenocarcinoma (LUAD) 105 prognosis prediction. We constructed a GRN for EMT, which has been demonstrated as 106 highly relevant to cancer metastasis and prognosis. On this network 4 types of omics 107 data (mRNA-Seq, miRNA-Seq, DNA methylation, and copy number alteration data) 108 were integrated and 10 feature selection algorithms were employed. We obtained both 109 single-and multi-omics EMT prognostic signatures, evaluated their prediction 110 performance, analyzed the biological interpretations, and performed survival analysis.
111
Furthermore, these signatures were tested on independent multi-omics LUAD data. We 112 showed that EMT prognostic signatures achieved remarkable prediction performance on 113 TCGA data. On independent data, both single-and multi-omics signatures stratified 114 patients into significantly different prognostic groups. Multi-omics signatures were 115 shown to be more robust than single-omics signatures.
116

Materials and methods
117
We will first describe the construction of EMT networks. This is followed by the 118 introduction of 10 feature selection algorithms. Then we explain the details of the 119 experiments.
120
EMT gene regulatory networks 121
As an up-to-date EMT GRN is not readily available, we constructed the network by 122 literature review. The network we constructed has incorporated key transcription 123 factors, miRNAs, their regulations and interactions with EMT hallmark molecules.
124
Multiple levels of gene regulations such as transcriptional, translational, and 125 post-translational regulations were covered. The reference for each component in the 126 network can be found in [37] . Since this network covers mainly driver genes, we named 127 it as the core network.
128
As it is observed, driver genes are often less differentially expressed than the genes 129 they regulate [35] . If one includes only the driver genes for identifying molecular [9] network by including the molecules that directly interact with or being regulated by the 132 molecules in the core network. NetworkAnalyst tool [38] was employed to find these 133 interactions, which consist of protein-protein interactions, miRNA-gene interactions, 134 and transcription factor-gene interactions. The resulting network was named extended 135 network. After constructing this network, we noticed that many features have a rather 136 low variance among samples, we thus removed these features and obtained the filtered 137 network. All three networks were employed in our experiments. The three networks 138 contain 74, 123 and 455 nodes respectively. Details of the networks can be found in [37] . 139
Experiments 140
We first obtained RNA-Seq, miRNA-Seq, DNA methylation, and CNA data of LUAD 141 from FIREHOSE Broad Genome Data Analysis Center website. mRNA-Seq and 142 miRNA-Seq data were combined because they both measure the abundance of 143 transcripts. This resulted in 3 data levels: gene expression, DNA methylation, and CNA 144 data. These three data levels will be abbreviated as GE, DM, and CNA in the remaining 145 text. Each data level was normalized feature-wise by subtracting the mean and dividing 146 by the standard deviation. More details of data pre-processing can be found in [37, 39] . 147 Since we have obtained 3 EMT networks and 3 data levels, feature selection can be 148 performed on each combination of network and data level. To evaluate whether 149 EMT-based feature selection can give more robust molecular signatures for prognosis 150 prediction, we employed 10 representative features selection algorithms to identify 151 signatures from EMT genes and EMT networks. Table 2 gives an overview of these 152 algorithms. Five of these algorithms integrate network information and the other five 153 algorithms use only omics data. The underlying methodologies are very different. We 154 suppose that if EMT network is superior for selecting prognostic signatures, the 155 performance of the selected features from the majority of these algorithms should show 156 improvements. As mentioned before, state-of-the-art studies usually use only gene expression data for feature selection. We instead incorporated three different omics data 158 levels. This gives us the possibility to compare and integrate the signatures from 159 different data levels.
160
Note that even the largest EMT network (the extended network) covers only 2.3% of 161 the original data dimensions. To assess the performance of EMT-based feature selection, 162 we compared the prediction performance of EMT signatures with the features selected 163 out of all features from the corresponding data levels. Additionally, random networks of 164 the same size and structure as EMT networks were generated -the nodes in the random 165 networks were randomly chosen from all the features of the corresponding data level. We performed the comparison by selecting features with the training set, using these 178 features to train an SVM classifier, and classifying samples on the cross-validation set. 179 Patients who survived more than 1400 days belong to the good prognosis group and 180 patients who survived less than 700 days belong to the poor prognosis group. The 181 results from 30 times stratified 10-fold cross-validation were averaged. Within each data 182 level the same cross-validation folds were used for all the feature selection algorithms on 183 all the comparative groups. The classification performance was evaluated using three 184 metrics: ROC-AUC, ROC-PR and accuracy. 185 We chose relatively stringent thresholds for feature selection, this is to reveal more 186 difference than similarities between the two patient groups. We argue that it becomes 187 harder to find the signatures if the two groups have more similar samples in terms of 188 the phenotype. For example, if one uses a single threshold of 3 years, we assume that 189 the molecular profiles of patients who survived a bit longer than 3 years may be very 190 similar to patients who survived a bit shorter than 3 years. In this case, it is challenging 191 to find the signatures that can capture the most important difference between the two 192 groups, given the limited amount of samples and their heterogeneity. However, we did 193 not omit the influence of thresholds. We tested the performance of all feature selection 194 algorithms with four different thresholds, in the order of increasing discrepancy: 3 years, 195 <900 or >1200 days, <700 or >1400 days, <500 or >1500 days.
196
Besides evaluating the classification performance, survival analysis was performed 197 using the selected features on censored data. The data have much more samples that 198 could not be included in classification.We think that if the selected features are good 199 signatures, they should be able to stratify the patients into significantly different 200 survival groups. We performed survival analysis on both all-stage and early-stage 201 patients. The sample sizes for classification and for survival analysis (all stage patients) 202 are given in Table 3 . mining approach to infer prognostic association rules. The rules have the advantage to 207 directly associate the states of the features to the phenotype of interest. We inferred 208 rules using EMT signatures from individual data levels and also from their different 209 combinations. Our motivation is to understand whether features from different data 210 levels complement each other and jointly contribute to patient prognosis. 211 We were able to show that EMT signatures from different data levels complement 212 each other in prognostic rules. This inspired us to obtain multi-omics EMT signatures 213 by combining the signatures on individual data levels (single-omics signatures). Both 214 single-and multi-omics EMT signatures were evaluated on TCGA data and 215 independent LUAD multi-omics data using survival analysis. All the data and code for 216 analysis are available at https://github.com/BorongShao/EMT prognosis-master. Next, we give the average AUC values of EMT signatures on all three data levels in 226  Table 4 . The boxplot is given in S2 Fig. These results show that features selected from 227 GE and DM data obtained better prediction performance than features selected from 228 CNA data. Depending on the data levels and network sizes, we find it hard to identify 229 the best-performing feature selection algorithm. In the last two lines of the table we give 230 the results of comparative groups 3 and 4. This shows that EMT signatures in many 231 cases outperformed features selected from all data level features. For example, with 232 Lasso feature selection algorithm, which was applied in both EMT feature space and in 233 the whole feature space, EMT signatures gave better predictions in more than half of 234 the cases. This indicates that selecting prognostic signatures from a much smaller 235 phenotype relevant network is a feasible approach. We also evaluated the performance 236 of the 10 feature selection algorithms with different classification thresholds. Both SVM 237 and random forest classifiers are employed. The results are given in S3 Fig. It shows 238 that regardless of feature selection algorithms, using more discrepant thresholds tends 239 to obtain higher AUC values. Meanwhile, a few algorithms such as addDA2, RegCox, 240 and Survnet are more sensitive to the effect of thresholds than the other algorithms. Although EMT signatures were shown to be significantly predictive in the experiments 243 above, we observed high variance in the AUC values from individual cross-validation EMT network were employed for the test, as this combination was shown in Table 4 255 and Figure 4 to give above-average prediction performance. We compared the 256 prediction performance of FSFs with that of individually selected features. The results 257 are given in Fig 2. The density plots and results of statistical tests are given in S4 Fig. 258 We observed that FSFs significantly outperformed individually selected features, 
• Lift. It indicates the degree to which X and Y depend on each other.
We binarized the EMT features using their means and applied Apriori algorithm 280 [53] to derive rules, with the constraints of conf idence ≥ 0.8 and support ≥ 0.1. The 281 algorithm was implemented in the textitarules R package [51] . Since we are trying to 282 find molecular patterns for predicting prognosis, we set the RHS of the rules to be the 283 class labels of prognosis.
284
The resulting rules show sound biological interpretations according to established 285 findings in cancer research. Here we interpret two rules identified from the core EMT 286 network:
287
{LOXL2 GE = high, T GF B1 GE = high, miR − 34a GE = low} ⇒ {prognosis = poor}, 288 with support = 0.135, conf idence = 1, lif t = 2.046. This rule applies to all samples 289 that have these 3 gene expression conditions. Biologically, it has been shown that 290 LOXL2 can stabilize SNAI1. TGFB1 can phosphorylate SMAD2 and SMAD3, which 291 interact with SMAD4 to activate HMGA2, which then activates SNAI1. When LOXL2 292 and TGFB1 are highly expressed, it not only induces SNAI1 gene expression but also 293 stabilizes SNAI1 protein. miR-34a has the role of repressing SNAI1. When miR-34a has 294 low gene expression, SNAI1 is less repressed. Taken together, these three conditions 295 point to the direction of the high expression of SNAI1 -a master transcription factor to 296 induce EMT. This contributes to poor prognosis. In contrast, another rule which has an 297 opposite LOXL2 state indicates good prognosis: 298 {LOXL2 GE = low, ET S1 GE = low, LOXL2 DM = high} ⇒ prognosis = good, with 299 support = 0.105, conf idence = 1, lif t = 1.956. In this scenario, LOXL2 has high DNA 300 methylation level and low gene expression level, and thus not able to stabilize SNAI1.
301
ETS1 gene is known to increase the expression of ZEB1 which induces EMT. In this 302 rule ETS1 has low expression so it does not contribute to inducing EMT. These factors 303 can contribute to good prognosis. S1 Table contains more examples.
304
From single-to multi-omics signatures 305 The FSFs above were obtained alternatively from single data levels. Therefore, we name 306 them as single-omics signatures. To investigate whether molecular signatures clustering algorithm are given in S2 Table. In both tables we observe that multi-omics 317 signatures improve sample stratifications significantly. An example is visualized in S5 318 Fig, S6 Fig, and S7 Fig.   319 Next, we performed survival analysis on early stage patients. The results are given 320 in Table 6 . It shows that EMT-based signatures can still stratify the patients into 321 significantly different prognostic groups.
322
Last but not least, we tested the performance of two integrative clustering 323 algorithms: SNF [54] and iCluster [55] with multi-omics EMT signatures. Briefly, SNF 324 algorithm constructs sample similarity networks using individual data levels and then clustering results we performed survival analysis. The results of log-rank tests are given 329 in S3 Table for SNF algorithm and in S4 Table for iCluster algorithm. We observed that 330 neither SNF nor iCluster algorithm yielded better sample stratifications than using 331 k-means algorithm ( Table 5 ).
332
Test results on independent data 333 We obtained the test data from [56] including 164 samples with DM data. 121 of these 334 samples have also mRNA expression data (microarray) available. The patient follow up 335 time ranges between 2 and 99 months with the median of 44 months. The outcome 336 (event) is defined as the occurrence of relapse, distant metastasis or death. The time to 337 event is calculated from the date of surgery. Detailed experimental procedures and the 338 processing of raw data are provided in [56] . EMT single-and multi-omics signatures 339 consisting of GE and DM data levels were evaluated on the test data using survival 340 analysis. EMT signatures were extracted from the test data without any additional 341 training or modifications. Hierarchical clustering, instead of k-means was employed in 342 order to compare our results with the original study [56] . 343 We have tested the EMT signatures selected by each feature selection algorithm [37] . 344 It is show that single-omics signatures can already stratify the samples into significantly 345 different prognostic groups. An example is given in Fig 3. Multi-omics signatures often 346 yielded better sample stratifications. Fig 4 shows an example where the multi-omics 347 signature from a feature selection algorithm can significantly stratify the samples while 348 the single-omics signatures cannot. Compared with the survival analysis results in the 349 original study [56] , we achieved more significant sample stratifications with EMT [22, 24, 35] . Some accredit this to the existence of a large number of genes 357 that are correlated with the target labels [12] . Given the limited amount of samples, it 358 becomes very hard to differentiate the marker genes and irrelevant genes. We addressed 359 this issue by constructing a phenotype relevant gene regulatory network, integrating 360 multiple types of omics data with the network to select molecular signatures. We have 361 shown that with lung cancer prognosis prediction, EMT signatures selected from only whole feature space. To the best of our knowledge, we for the first time constructed a 364 phenotype-relevant GRN for lung cancer prognosis prediction.
365
Previously we employed EMT networks for selecting lung cancer prognostic 366 signatures [39, 57] . However, [57] used mRNA expression and miRNA expression data 367 only. [39] employed three data levels for feature selection but obtained no significant 368 improvement in predictions. In this study, we extended the EMT network to 369 incorporate its interacting molecules. Besides, we reviewed the network used in [39] and 370 removed the edges which denote associations rather than direct gene regulations. What 371 also distinguishes this study from our previous work is the employment of 10 372 representative feature selection algorithms, instead of decomposing the network into 373 network motifs [39, 57] . We have selected EMT signatures on three data levels with 374 different network sizes, compared with the features selected from the whole data 375 dimensions, and derived prognostic rules from EMT signatures. Furthermore, we 376 obtained multi-omics signatures and showed their superior prediction performance over 377 single-omics signatures. This shows that signatures from multiple omics data types can 378 complement each other to better distinguish different phenotypes.
379
The potential of EMT molecules in prognosis prediction has also been studied before. 380 [61] and [62] performed survival analysis using individual EMT hallmark molecules 381 such as E-cadherin and vimentin and showed that none of these molecules could 382 separate LUAD or bladder cancer patients into significantly different prognostic groups. 383 Note that these conclusions were drawn from mainly univariate analysis. Since the 384 molecules jointly contribute to the phenotype, it could be more helpful to use a set of 385 features. This can be seen also from the prognostic association rules derived from EMT 386 signatures, where EMT molecules are jointly associated with the phenotype. All in all, 387 we successfully demonstrated that EMT network-based feature selection and data 388 integration can provide advantages in selecting cancer prognostic signatures. 
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